Stryker (SYK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road
Investors with an interest in Medical - Products stocks have likely encountered both Haleon PLC Sponsored ADR (HLN) and Stryker (SYK). But which of these two stocks is more attractive to value investo
There is more to the comparison, and in the sections below, we discuss why we believe that SYK will offer better returns than BAX in the next three years.
Stryker (SYK) reported earnings 30 days ago. What's next for the stock?
Stryker (SYK) successfully completes first surgical case using its Q Guidance system with Cranial Guidance software. An Early Product Surveillance is underway for the combined technology.
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.

3 Healthcare Trends to Ride for Longevity

05:21pm, Monday, 22'nd May 2023
Because of their longevity, predictability, and stability, healthcare trends can persist for years. The companies covered today are fundamentally and technically robust stocks currently taking advanta
Investors interested in stocks from the Medical - Products sector have probably already heard of Haleon PLC Sponsored ADR (HLN) and Stryker (SYK). But which of these two stocks presents investors with
Stryker and Medtronic are two of the biggest names in the medical device industry. Stryker is growing steadily, and its recent headwinds are clearing up.
Warren Buffett held court again at Berkshire Hathaway's shareholder meeting. But his company could learn from some other S&P 500 companies.
Stalwarts are companies that have stood the test of time without trouble. Thermo Fisher's recent headwinds should have little impact on its long-term outlook.
Investors interested in stocks from the Medical - Products sector have probably already heard of Baxter International (BAX) and Stryker (SYK). But which of these two stocks is more attractive to value
Stryker's (SYK) first-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurts sales growth and rising costs affect margins.
Stryker Corporation (NYSE:SYK ) Q1 2023 Earnings Conference Call May 1, 2023 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Jason Beach - Vice President, Investor Relat
Stryker (SYK) came out with quarterly earnings of $2.14 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $1.97 per share a year ago.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE